Zhou Hongqing, Zhang Tingting, Chen Liang, Cui Fengzhen, Xu Chenxiang, Peng Jiaxi, Ma Weixiang, Huang Jirong, Sheng Xia, Liu Mingsheng, Zhao Faming
The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China.
Key Laboratory of Environmental Health, Ministry of Education & Ministry of Environmental Protection, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
FASEB J. 2023 Feb;37(2):e22758. doi: 10.1096/fj.202201347R.
Stress in the endoplasmic reticulum (ER) may perturb proteostasis and activates the unfolded protein response (UPR). UPR activation is frequently observed in cancer cells and is believed to fuel cancer progression. Here, we report that one of the three UPR sensors, ATF6α, was associated with prostate cancer (PCa) development, while both genetic and pharmacological inhibition of ATF6α impaired the survival of castration-resistance PCa (CRPC) cells. Transcriptomic analyses identified the molecular pathways deregulated upon ATF6α depletion, and also discovered considerable disparity in global gene expression between ATF6α knockdown and Ceapin-A7 treatment. In addition, combined analyses of human CRPC bulk RNA-seq and single-cell RNA-seq (scRNA-seq) public datasets confirmed that CRPC tumors with higher ATF6α activity displayed higher androgen receptor (AR) activity, proliferative and neuroendocrine (NE) like phenotypes, as well as immunosuppressive features. Lastly, we identified a 14-gene set as ATF6α NE gene signature with encouraging prognostic power. In conclusion, our results indicate that ATF6α is correlated with PCa progression and is functionally relevant to CRPC cell survival. Both specificity and efficacy of ATF6α inhibitors require further refinement and evaluation.
内质网(ER)应激可能会扰乱蛋白质稳态并激活未折叠蛋白反应(UPR)。UPR激活在癌细胞中经常被观察到,并且被认为会促进癌症进展。在此,我们报告三个UPR传感器之一的ATF6α与前列腺癌(PCa)的发展相关,而对ATF6α的基因抑制和药物抑制均会损害去势抵抗性PCa(CRPC)细胞的存活。转录组分析确定了ATF6α缺失后失调的分子途径,并且还发现了ATF6α敲低与Ceapin-A7处理之间在全局基因表达上的显著差异。此外,对人类CRPC批量RNA测序和单细胞RNA测序(scRNA-seq)公共数据集的联合分析证实,具有较高ATF6α活性的CRPC肿瘤表现出较高的雄激素受体(AR)活性、增殖和神经内分泌(NE)样表型以及免疫抑制特征。最后,我们确定了一个14基因集作为ATF6α的NE基因特征,具有令人鼓舞的预后能力。总之,我们的结果表明ATF6α与PCa进展相关,并且在功能上与CRPC细胞存活相关。ATF6α抑制剂的特异性和有效性都需要进一步优化和评估。